Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Update on Legislation, Advocacy Efforts to Advance Rheumatology

Joseph Flood, MD  |  Issue: September 2014  |  September 1, 2014

Many ACR/ARHP members and their patients were on Capitol Hill this year to advance rheumatology by discussing important issues and building relationships with decision makers.

It’s September, and that means that again this year many ACR/ARHP members and their patients were on Capitol Hill Advancing Rheumatology! by discussing important issues and continuing to build relationships with decision makers. I am proud of this work done during the annual Advocates for Arthritis event. I thought I would take this opportunity to provide an update on legislative activities. As we all know, the govern­ment influences our subspecialty in numerous and potent ways. I cannot cover every issue we are addressing, but I will highlight some of the most significant on which your colleagues and the ACR are focusing.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Advocacy has always been near to my heart. I have been delighted to watch how the scope and effectiveness of the Committee on Government Affairs (GAC) has grown, and I am proud of our sophisticated approach to federal and, now, state issues. Through the efforts of our volunteer leaders, staff, lobbyists and advocates, we are able to stay nimble and make headway in Washington, D.C. The Simple Tasks campaign has also been of great value in helping legislators know us and remember us (www.simpletasks.org). In an election year, with so many issues (including international crises) competing for attention, we still have managed to move your priorities forward. Most of our issues currently fall into three categories: access to rheumatology, access to treatment and funding for research.

If rheumatologists & rheumatology health professionals are not adequately paid, then patients’ access to our expert care will be jeopardized.

Access to Rheumatology

The sustainable growth rate (SGR) payment formula, which continues to mandate massive cuts and requires congressional rescue each year, remains a focus. I know some members think our annual struggle for relief from the anxieties of the SGR is a Sisyphean task, but the ACR and GAC do not, and so it continues to demand our action. If rheumatologists and rheumatology health professionals are not adequately paid, then patients’ access to our expert care will be jeopardized. This year we have made meaningful progress. In fact, in 2014, for the first time ever, a bill to permanently repeal and replace the SGR was passed in Congress. H.R. 4015 passed along party lines. However, because the mechanism to pay for the “fix” was felt to be partisan, it had no chance of being passed in the Senate.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Billing/CodingBiologics/DMARDsDrug UpdatesLegislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/ImprovementResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BillingBiologicsBiosimilarsCodingdrugICD-10LegislationMedicarePractice ManagementResearchrheumatologistSGRTechnology

Related Articles
    Prepare NOW for ICD-10 Medical Coding Transition

    Prepare NOW for ICD-10 Medical Coding Transition

    July 14, 2015

    The ICD-10 page on the Centers for Medicare & Medicaid Services (CMS) website features a countdown clock that shows the time left until Oct. 1, 2015, the date on which compliance with the new code set becomes mandatory. By the time this issue goes to press, the clock will read 90 or fewer days. Time…

    President’s Perspective: ACR Addresses Reform of Sustainable Growth Rate Formula

    December 1, 2013

    The College’s multi-pronged plan to replace flawed SGR payment system requires continued support from rheumatologists, healthcare professionals

    Plan Now for ICD-10 Changeover

    May 16, 2011

    Coding changes will have an impact on staff, physicians, and even the finances of rheumatology practices

    A Fork in the Road: Advocacy for Rheumatology

    July 10, 2012

    Is that fork bent? So you must be a rheumatologist.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences